RESEARCH PAPER
Health-related quality of life in children and adolescents after systemic sting reaction
 
More details
Hide details
1
DZIUPLA Statistical analysis, Krakow, Poland
 
2
Department of Paediatrics, Jagiellonian University Medical College, Krakow, Poland
 
 
Corresponding author
Ewa Cichocka-Jarosz   

Jagiellonian University Medical College, Department of Pediatrics
 
 
Ann Agric Environ Med. 2019;26(1):103-108
 
KEYWORDS
TOPICS
ABSTRACT
Introduction and objectives:
Insect stings are the second trigger of anaphylaxis in children and adolescents, causing a potentially life-threatening reactions. Hence health-related quality of life (HRQoL) is an important issue for Hymenoptera venom allergy (HVA) patients. The aim of this cross-sectional study was to evaluate the impact of HVA on young patients’ HRQoL, including their socio-demographic characteristics.

Material and methods:
The study sample included 102 patients aged 8–17 (Mean 12.5 years, SD=3.0), who were under diagnosis or venom immunotherapy due to systemic reaction after an insect sting in one of the tertiary referential centers in Poland. They were mostly boys (70%), and mainly from rural areas (63%). HRQoL of studied patients was measured with the Children’s Hymenoptera Venom Allergy Quality of Life Scale, a questionnaire covering 6 dimensions: anxiety, caution, limitations, discomfort, support received from parents and a feeling of safety, each measured from 1 to 5. Independent predictors of HRQoL were estimated using the Generalized Linear Model.

Results:
In the group of children being dermal reactors, girls reported a higher level of anxiety (B=1.17, 95%CI=(0.30;2.03), p=0.008). In the group of children with grade 2 it was the girls who reported lower anxiety (B=-1.33, 95%CI=(-2.38;-0.29), p=0.013). Boys treated longer than 3 years had their level of anxiety significantly lower than those studied at diagnosis (B=-0.65, 95%CI=(-1.23;-0.07), p=0.028). The feeling of safety was higher in children living in villages than in those living in towns (B=0.30, 95%CI=(0.03;0.56), p=0.031).

Conclusions:
The gender, treatment duration and stage of anaphylactic reaction influenced level of anxiety. The level of feeling of safety was related to the place of living.

ACKNOWLEDGEMENTS
The authors express their thanks to Matylda Gawor for critical review of the text as the English proofreader.
 
REFERENCES (29)
1.
Carr A, Higginson I, Robinson P. Quality of life. London, BMJ, 2003.
 
2.
Worm M, Francuzik W, Renaudin JM, Bilo MB, Cardona V, Scherer Hofmeier K, et al. Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry. Allergy. 2018; doi: 10.1111/all.13380.
 
3.
Biló BM, Rueff F, Mosbech H, Bonifazi F, Oude-Elberink JNG, the EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of Hymenoptera venom allergy. Allergy. 2005; 12: 1339–1349.
 
4.
Cichocka-Jarosz E, Brzyski P, Tobiasz-Adamczyk B, Lis G, Pietrzyk JJ. Development of Children’s Hymenoptera Venom Allergy Quality of Life Scale (CHVAQoLS). Clin Translational Allergy. 2013; 3: 25.
 
5.
Taminskiene V, Vaitkaitiene E, Valiulis A, Turner S, Hadjipanayis A, Stukas R, et al. The self-reported quality of life of Lithuanian children with asthma was comparable to Western populations. Acta Paediatr. 2018; 107: 333–338.
 
6.
Silny W, Bartoszak L, Jenerowicz D, Żukiewicz-Sobczak W, Goździewska M. Prevalence of contact allergy in children suffering from atopic dermatitis, seborrhoeic dermatitis and in healthy controls. Ann Agric Environ Med. 2013; 20: 55–60.
 
7.
Yamaguchi C, Futamura M, Chamlin SL, Ohya Y, Asano M. Development of a Japanese Culturally Modified Version of the Childhood Atopic Dermatitis Impact Scale (JCMV-CADIS). Allergol Int. 2016; 65: 312–319.
 
8.
La Grutta S, Landi M, Braido F, Montalbano L, Ferrante G, Malizia V, et al. RHINASTHMA-Adolescents: a new quality of life tool for patients with respiratory allergy. Pediatr Allergy Immunol. 2014; 25: 450–455.
 
9.
Kłak A, Mińko M, Siwczyńska D, Samoliński B. Selected questionnaire methods studying the quality of life. Adv Dermatology Allergol. 2015; 3: 210–215.
 
10.
Storch EA, Small BJ, McGuire JF, Murphy TK, Wilhelm S, Geller DA. Quality of Life in Children and Youth with Obsessive-Compulsive Disorder. J Child Adolesc Psychopharmacol. 2018; 28: 104–110.
 
11.
Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, et al. Venom immunotherapy for preventing allergic reactions to insect stings. The Cochrane database of Systematic Reviews. 2012; doi: 10.1002/14651858.CD008838.pub2.
 
12.
Cichocka-Jarosz E, Brzyski P. Children’s Hymenoptera Venom Allergy Quality of Life Scale (CHVAQoLS) official webpage. http://www.chvaqols.cm-uj.krak.... (access: 2015.01.05).
 
13.
Brzyski P, Cichocka-Jarosz E, Tobiasz-Adamczyk B, Lis G, Jedynak-Wąsowicz U, Pietrzyk JJ, et al. Adaptacja kwestionariuszy jakości życia dla dzieci z alergią na jad owadów oraz dla ich rodziców [Adaptation of Vespide Allergy Quality of Life Questionnaire for Polish children with venom allergy and for their parents]. Przegl Lek. 2010; 12: 1237–1242.
 
14.
Brzyski P, Cichocka-Jarosz E, Tobiasz-Adamczyk B, Lange J, Świebocka E, Lis G, et al. Theoretical validity and reliability of Vespide Quality of Life Questionnaire in Polish adolescents with Hymenoptera venom allergy. Adv Dermatology Allergol. 2012; 1: 8–13.
 
15.
Tobiasz-Adamczyk B, Brzyski P, Cichocka-Jarosz E. Jakość życia chorych z alergią na jad owadów [Quality of life of patients with venom allergy]. In: Nittner-Marszalska M, editor. Alergia na owady [Insect allergy]. Łódź, Mediton Oficyna Wydawnicza, 2016. p. 105–123.
 
16.
Cichocka-Jarosz E, Brzyski P, Świebocka E, Lange J, Tobiasz-Adamczyk B, Lis G, et al. Health-related quality of life in Polish adolescents with Hymenoptera venom allergy treated with venom immunotherapy. Arch Med Sci. 2012; 6: 1076–1082.
 
17.
Cichocka-Jarosz E, Tobiasz-Adamczyk B, Brzyski P, Lis G, Jedynak-Wąsowicz U, Pietrzyk JJ, et al. Jakość życia warunkowana stanem zdrowia dzieci z alergią na jad owadów błonkoskrzydłych leczonych VIT oraz jakość życia ich rodziców [Health-related quality of life in children with Hymenoptera venom allergy treated with VIT and quality of life of their parents]. Przegl Lek 2010; 12: 1243–1248.
 
18.
Jaworowska A. Inwentarz stanu i cechy lęku dla dzieci STAIC C.D. Spielbergera, C.D. Edwardsa, R.E. Lyushene’a, J. Montuoriego i D. Platzek [State and trait anxiety inventory STAIC by C.D. Spielberger, C.D. Edwards, R.E. Lyushene, J. Montuori and D. Platzek]. Warszawa, Pracownia Testów Psychologicznych Polskiego Towarzystwa Psychologicznego, 2005.
 
19.
Studenski R. Ryzyko i ryzykowanie [Risk and Risk taking]. Katowice, Wydawnictwo Uniwersytetu Śląskiego, 2004.
 
20.
Oude-Elberink JNG, de Konchy JGR, Golden DBK, Brouwer J-LP, Guyatt GH, Dubois AEJ, et al. Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol. 2002; 1: 162–170.
 
21.
Oude Elberink JNG, Dubois AEJ. Quality of life in insect venom allergic patients. Curr Opin Allergy Clin Immunol. 2003; 3: 287–293.
 
22.
Niedoszytko M, Majkowicz M, Chełmińska M, Buss T, Gruchała-Niedoszytko M, Jassem E. Quality of life, anxiety, depression and satisfaction with life in patients treated with insect venom immunotherapy. Adv Dermatology Allergol. 2012; 2: 74–79.
 
23.
Fischer J, Feidt A, Giel KE, Martens U, Zipfel S, Biedermann T, Teufel M. Quality-of-life in wasp venom allergy – validation of the German version of the “Vespid Allergy Quality of Life Questionnaire”(VQLQ-d). JDDG; 2011; 9: 379–385.
 
24.
Koschel DS, Schmies M, Nink Weber C, Höffken G, Balck F. Tolerated Sting Challenge in Patients on Hymenoptera Venom Immunotherapy Improves Health-Related Quality of Life, J Investig Allergol Clin Immunol. 2014; 24: 226–230.
 
25.
Alfaya T, Vega A, Domínguez-Noche C, Ruiz B, Marqués L, Sánchez-Morillas L. Longitudinal Validation of the Spanish Version of the Health-Related Quality of Life Questionnaire for Hymenoptera Venom Allergy (HRQLHA). J Investig Allergol Clin Immunol. 2015; 25: 426–430.
 
26.
Armisén M, Guspi R, Alfaya T, Cruz S, Fernández S, Domínguez-Noche C, Alonso A, Dalmau G, Marqués L, Vega A. Cross-Sectional Validation of a Quality of Life Questionnaire in Spanish for Patients Allergic to Hymenoptera Venom. J Investig Allergol Clin Immunol. 2015; 25: 107–111.
 
27.
Sin BA, Öztuna D, Gelincik A, Gürlek F, Baysan A, Sin AZ, Aydın Ö, Mısırlıgil Z. Quality-of-life in insect venom allergy: validation of the Turkish version of the “Vespid Allergy Quality of Life Questionnaire”(VQLQ-T), SpringerPlus 2016; 5: 583, DOI 10.1186/s40064-016-2246-x.
 
28.
Silva D, Pereira AM, Santo SN, Amaral L, Delgado L, Oude Elberink J.N.G. (H.), Coimbra A. The Vespid Allergy Quality of Life Questionnaire – cultural adaptation and translation to Portuguese. Eur Ann Allergy Clin Immunol. 2017; 49: 114–121.
 
29.
Schumacker RE, Lomax RG. A beginner’s guide to structural equation modelling, Second edition. Mhawah: Lawrence Erlbaum Associates 2004.
 
eISSN:1898-2263
ISSN:1232-1966
Journals System - logo
Scroll to top